AM Medical Virtual Summit: Northeastern University & OPM Discuss Bacterial Inhibition via 3D-Printed PEKK
Oxford Performance Materials (OPM) presented new findings on 3D printing with biocompatible materials at the AM Medical Virtual Summit. Focused on the fabrication of medical implants for bone regeneration, the Windsor, Connecticut-headquartered company attended the conference with James Porteus, Director of Engineering, Oxford Performance Materials, Inc., Israr Kabir, Business Development Manager, ASME, and Thomas Webster, Art Zafiropoulo Chair and Professor at Northeastern University leading the presentation on ‘3D Printed PEKK Polymer: Enabling a Family of Medical Devices that Inhibit Bacterial Growth without the Use of Antibiotics.’
PEKK (poly-ether-ketone-ketone) was at the center of the presentation. Porteus began by explaining that as a 3D-printed material, PEKK has been found to be amenable to bone integration, ongrowth, and ingrowth—while also presenting antibacterial qualities.
Quality of bone and integration are critical also, and both aspects were examined comprehensively during research with an ovine model—again showing ‘notable’ ingrowth when compared to other popular AM materials such as titanium and PEEK.
As Thomas Webster explained, biocompatibility and bone growth is one major advantage with PEKK; however, just as important is the collaborative research between Northeastern University and OPM in bacteria inhibition studies. Sharing CDC data, Webster states that it is expected that more people will die from antibacterial-resistant bacteria than all cancers combined by the year 2050.
Properties such as those found in PEKK assist in wound-healing applications, devices created for amputees, and medical equipment like catheters. Webster went on to explain that nanofeatures, found all over nature—from the wings of a cicada to a locust—provide antibacterial properties as surface energy is manipulated in a streamlined manner. The researchers noted that PEKK not only allows greater adsorption of antibacterial proteins like casein—but also mucin and lubricin.
“We are seeing great ability to control cell function, whether it’s decreasing bacteria, decreasing inflammation, or promoting tissue growth just using nanotextures without drugs,” said Webster. “What we are finding is nanotextures are a great thing. If you can create them appropriately, if you have a process that can create them and a material that can have nanostructure features, we are seeing properties with increased bone growth on 3D printed metals.”
Numerous in vitro responses to PEKK showed that without antibiotics, PEKK inhibited bacteria colonization—compared with other materials like titanium and PEEK in the presence of staphylococcus, pseudomonas aeruginosa, and methicillin-resistant staphylococcus aureus (MRSA); it was noted also that for MRSA, the great decrease was noted with PEKK samples. Taking the COVID-19 pandemic into consideration also, the researchers are now becoming more curious about exploring the effects of materials like PEKK on viruses.
“Of those cells, a significantly lower number are alive,” states Webster, further discussing the advantages of PEKK in comparison to titanium and PEEK.
In closing, Webster stated that one of the major results of the study was in understanding the ‘mechanism of action’ for PEKK as it allows for better adsorption of antibacterial proteins.
We have followed the research of OPM for years, as well as Northeastern’s advances in 3D printing. What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.3D Printed PEKK Polymer: Enabling a Family of Medical Devices that Inhibit Bacterial Growth without the Use of Antibiotics’ – as presented on May 27th, 2020 at the AM Medical Virtual Summit]
You May Also Like
3D Printing Webinar and Event Roundup: September 12, 2021
Buckle your seatbelts, it’s going to be a busy week of webinars and events, both virtual and in-person! RAPID + TCT and FABTECH will both be held in-person this week...
Sixth Bioprinting Acquisition in One Year from Cellink Parent Company BICO
Pioneering bioprinting firm Cellink, now part of a larger company rebranded as BICO (short for bioconvergence), has already been making quite a name for itself and is preparing to capture...
Complete Tumor 3D Printed to Facilitate Faster Treatment Prediction
There are more than 120 different types of brain tumors, many of which are cancerous, but the deadliest, and sadly most common, is the aggressive, fast-growing glioblastoma multiforme (GBM), a...
3D Printing Webinar and Event Roundup: August 15th, 2021
From convincing your professor they need a 3D printer and the future of static mixers to biomaterials and bioprinting, we’ve got another week of webinars and events to tell you...
View our broad assortment of in house and third party products.